Search results
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
ETF DAILY NEWS· 13 hours agoResearch analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating ...
I Can See Clearly Now: Eye Care for Seniors Begins at 50 - The Baltimore Times
Baltimore Times· 5 days agoIf you can recall the Johnny Nash 70’s chart-topping hit “I Can See Clearly Now” or grew up watching...
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
Napa Valley Register· 2 days agoPharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today that ...
12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
Insider Monkey via Yahoo Finance· 5 days agoIn this article, we will be taking a look at the 12 cheap foods with anti-aging properties that...
Saffron and sight: Study explores longer-term effects
Nutraingredients.com· 1 day agoAccording to a recent study published in BMJ Open Ophthalmology, 12 months of saffron...
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic...
Morningstar· 2 days ago(Jort) Vijverberg, MD, PhD of the Alzheimer Center Amsterdam and Neuroscience Amsterdam. “The KOL roundtable we conducted featured a panel of Alzheimer’s disease expert clinicians and researchers ...
Local women with low vision gather to share experiences, advances in tech
telegraphherald.com· 3 days agoA group of nearly 20 women who either have low vision or are a friend or caregiver of someone with...
Ocugen (NASDAQ:OCGN) Given New $5.00 Price Target at Chardan Capital
ETF DAILY NEWS· 2 days agoOcugen (NASDAQ:OCGN – Get Free Report) had its price objective increased by stock analysts at Chardan Capital from $4.00 to $5.00 in a research report issued on Monday, Benzinga reports. Chardan ...
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer
Morningstar· 5 days agoLeiden, The Netherlands, 19 April 2024 – Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including ...
Brokers Offer Predictions for Unity Biotechnology, Inc.’s FY2024 Earnings (NASDAQ:UBX)
ETF DAILY NEWS· 5 days agoUnity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Equities research analysts at HC Wainwright raised their FY2024 EPS estimates for shares of Unity Biotechnology in a note issued to investors ...